Pharmacodynamic: Clinical Trials

6 trials for Pharmacodynamic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 3 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Unknown 1
Phase 13Completed 3

Follow Pharmacodynamic: new trials by email Literature Review of Pharmacodynamic trials Research Report on Pharmacodynamic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
Vamorolone, Eplerenone, Fludrocortisone - Pharmacodynamic
Phase 1CompletedSanthera Pharmaceuticals302024-06-052025-09-11
Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients
Dose prediction using population pharmacokinetic models - Febrile Neutropenia, Pharmacokinetics
Not applicableUnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1002022-12-312022-12-27
Pharmacodynamic Evaluation of Intranasal Nalmefene
Nalmefene hydrochloride, Naloxone hydrochloride - Pharmacodynamic
Phase 1CompletedOpiant Pharmaceuticals Inc842021-03-302025-07-14
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
Meropenem standard dose, Meropenem high dose - Sepsis, Septic Shock
Not applicableCompletedMahidol University762017-11-272019-03-12
To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
CLR 500mg, CJ-12420 100mg, CJ-12420 50mg - Drug Interaction, Pharmacokinetic
Phase 1CompletedHK inno.N Corporation602016-05-012017-05-12
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
betaine hydrochloride, Rabeprazole - Pharmacodynamic
Not applicableCompletedUniversity of California, San Francisco62011-03-012013-07-02

Narrower conditions

Critical Illness (1)  ·  Febrile Neutropenia (1)  ·  Multiple Organ Failure (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Broader conditions

Agranulocytosis (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)  ·  Neutropenia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Shock (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Amoxicillin (1)  ·  Betaine (1)  ·  Clarithromycin (1)  ·  Drugs, Investigational (1)  ·  Eplerenone (1)  ·  Fludrocortisone (1)  ·  Meropenem (1)  ·  Naloxone (1)  ·  Pantoprazole (1)  ·  Rabeprazole (1)  ·  VBP15 compound (1)  ·  nalmefene (1)

Sponsors

HK inno.N Corporation (1)  ·  Mahidol University (1)  ·  Opiant Pharmaceuticals Inc (1)  ·  Santhera Pharmaceuticals (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)  ·  University of California, San Francisco (1)

Countries

United States (2)  ·  Germany (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Jae-Gook Shin (1)  ·  Leslie Benet, PhD (1)  ·  Shawn Searle, MD (1)  ·  Steffen Haffner, MD (1)  ·  Tospon Lertwattanachai, B.sc.(Pharm) (1)  ·  Yudong Qiu (1)

Results publications

PMID 32318268, PMID 40957504